Fresh analysis suggests that patients who come off blockbuster weight-loss injections like Wegovy and Mounjaro can put back on shed pounds far faster than those who halt traditional lifestyle regimens.
Published data in a major medical journal demonstrates that while obese people often shed substantial amounts of their body weight while undergoing treatment, the weight is regained at an average rate of 0.8 kg per month once they quit.
"Individuals buying such drugs need to be aware of the potential of rapid rebound weight gain when the treatment is stopped," cautioned expert Dr. Susan Jebb.
That rate of regain implies a reversion to original weight in about 18 months.
Weighing Approaches
The research, which looked at dozens of trials involving over 9,000 of participants, contrasted the outcomes of GLP-1 agonists with conventional dieting.
The team emphasize that individuals who shed pounds through dieting usually experience a slower weight regain—perhaps 0.1 kg a month—once they finish.
Explaining the Rapid Rebound
Experts suggest the mechanism of the drugs explains the accelerated rebound.
These medications copy a natural hormone called glucagon-like peptide-1, which controls hunger.
"Sustained high doses of the hormone levels far above than normal may cause the system to produce less of its own natural hormone, and could reduce sensitivity to its effects," said Dr. Adam Collins, a nutrition expert.
"Stopping of this medication leads to hunger is uncontrolled, making overeating much more probable."
A Lifelong Condition?
Health authorities recommend the injections for people with weight-linked medical conditions, alongside prescribed lifestyle changes.
Many experts contend that, considering the high risk of weight regain, the therapy should be considered long-term.
This perspective is echoed by pharmaceutical companies, who say that the results "highlight the persistent character of excess weight," similar to managing conditions like high blood pressure.
User Testimonies
People who have come off the medication describe a intense resurgence of appetite.
"It was like a switch flipping and I was suddenly starving," described a patient.
This difficulty is worsened if users have not developed sustainable lifestyle or habit changes during treatment.
Widespread Interest
Recent estimates indicate that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with desire being substantial.
- Use is greater among females compared to males.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion obtain the medications through private healthcare rather than public health services.
In conclusion, experts emphasize that while the jabs are effective agents for shedding pounds, they are not a permanent solution and lasting health benefits likely depends on integrated lifestyle management.
